Zumutor Biologics
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $18M
Investors
- 4
About Zumutor Biologics
Zumutor Biologics Inc. is a US-based biotechnology firm focused on developing innovative NK cell therapeutics to enhance innate immunity and target tumors effectively. Founded in 2013 and headquartered in Cambridge, Massachusetts, Zumutor Biologics specializes in NK cell therapeutics. Kavitha Rodrigues, the CEO and founder, has directed the company's focus toward proprietary therapeutic advancements. In June 2026, Zumutor Biologics Inc. Zumutor Biologics specializes in developing targeted NK cell therapeutics, utilizing its Human Antibody platform, INABLR®. The lead product, the Anti-LLT1 monoclonal antibody, targets LLT1 for treating malignancies such as prostate cancer, B-cell lymphoma, and glioblastoma. The company operates R&D facilities in Cambridge, Massachusetts, and Bangalore, India, aiming to enhance patient outcomes through targeted therapies in oncology and immune-mediated diseases. Zumutor Biologics generates revenue primarily through partnerships and collaborations with healthcare institutions and pharmaceutical companies, utilizing licensing agreements and service contracts for clinical testing of its monoclonal antibodies. Financial specifics regarding individual products have not been disclosed, yet the Anti-LLT1 mAb is expected to significantly impact future revenue as it advances in clinical trials.
Who invested in Zumutor Biologics
4 investors across 3 rounds
See all investors in Zumutor Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zumutor Biologics
Who invested in Zumutor Biologics?
Zumutor Biologics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zumutor Biologics raised?
Zumutor Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zumutor Biologics last raise money?
Zumutor Biologics's most recent round on record is a Series A, in Jun 2026.
What does Zumutor Biologics do?
Zumutor Biologics is a biotechnology company.
Where is Zumutor Biologics headquartered?
Zumutor Biologics is headquartered in Cambridge, US.
Which VCs invest in companies like Zumutor Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zumutor Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Zumutor Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.